Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.

Bibliographic Details
Title: Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.
Authors: Mazziotti, Valentina, Crescenzo, Francesco, Tamanti, Agnese, Dapor, Caterina, Ziccardi, Stefano, Guandalini, Maddalena, Colombi, Annalisa, Camera, Valentina, Peloso, Angela, Pezzini, Francesco, Turano, Ermanna, Marastoni, Damiano, Calabrese, Massimiliano
Source: Biomedicines; Dec2022, Vol. 10 Issue 12, p3034, 11p
Subject Terms: IMMUNE response, COVID-19 vaccines, MULTIPLE sclerosis, INFLAMMATORY mediators, PEARSON correlation (Statistics)
Abstract: The impact of disease-modifying therapies (DMTs) on the immune response to coronavirus disease-2019 (COVID-19) vaccines in persons with multiple sclerosis (pwMS) needs further elucidation. We investigated BNT162b2 mRNA COVID-19 vaccine effects concerning antibody seroconversion, inflammatory mediators' level and immunophenotype assessment in pwMS treated with cladribine (c-pwMS, n = 29), fingolimod (f-pwMS, n = 15) and ocrelizumab (o-pwMS, n = 54). Anti-spike immunoglobulin (Ig)-G detection was performed by an enzyme immunoassay; molecular mediators (GrB, IFN-γ and TNF-α) were quantified using the ELLA platform, and immunophenotype was assessed by flow cytometry. ANCOVA, Student's t-test and Pearson correlation analyses were applied. Only one o-pwMS showed a mild COVID-19 infection despite most o-pwMS lacking seroconversion and showing lower anti-spike IgG titers than c-pwMS and f-pwMS. No significant difference in cytokine production and lymphocyte count was observed in c-pwMS and f-pwMS. In contrast, in o-pwMS, a significant increase in GrB levels was detected after vaccination. Considering non-seroconverted o-pwMS, a significant increase in GrB serum levels and CD4+ T lymphocyte count was found after vaccination, and a negative correlation was observed between anti-spike IgG production and CD4+ T cells count. Differences in inflammatory mediators' production after BNT162b2 vaccination in o-pwMS, specifically in those lacking anti-spike IgG, suggest a protective cellular immune response. [ABSTRACT FROM AUTHOR]
Copyright of Biomedicines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edb&genre=article&issn=22279059&ISBN=&volume=10&issue=12&date=20221201&spage=3034&pages=3034-3044&title=Biomedicines&atitle=Immune%20Response%20after%20COVID-19%20mRNA%20Vaccination%20in%20Multiple%20Sclerosis%20Patients%20Treated%20with%20DMTs.&aulast=Mazziotti%2C%20Valentina&id=DOI:10.3390/biomedicines10123034
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: edb
DbLabel: Complementary Index
An: 160942443
RelevancyScore: 957
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 957.281066894531
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Mazziotti%2C+Valentina%22">Mazziotti, Valentina</searchLink><br /><searchLink fieldCode="AR" term="%22Crescenzo%2C+Francesco%22">Crescenzo, Francesco</searchLink><br /><searchLink fieldCode="AR" term="%22Tamanti%2C+Agnese%22">Tamanti, Agnese</searchLink><br /><searchLink fieldCode="AR" term="%22Dapor%2C+Caterina%22">Dapor, Caterina</searchLink><br /><searchLink fieldCode="AR" term="%22Ziccardi%2C+Stefano%22">Ziccardi, Stefano</searchLink><br /><searchLink fieldCode="AR" term="%22Guandalini%2C+Maddalena%22">Guandalini, Maddalena</searchLink><br /><searchLink fieldCode="AR" term="%22Colombi%2C+Annalisa%22">Colombi, Annalisa</searchLink><br /><searchLink fieldCode="AR" term="%22Camera%2C+Valentina%22">Camera, Valentina</searchLink><br /><searchLink fieldCode="AR" term="%22Peloso%2C+Angela%22">Peloso, Angela</searchLink><br /><searchLink fieldCode="AR" term="%22Pezzini%2C+Francesco%22">Pezzini, Francesco</searchLink><br /><searchLink fieldCode="AR" term="%22Turano%2C+Ermanna%22">Turano, Ermanna</searchLink><br /><searchLink fieldCode="AR" term="%22Marastoni%2C+Damiano%22">Marastoni, Damiano</searchLink><br /><searchLink fieldCode="AR" term="%22Calabrese%2C+Massimiliano%22">Calabrese, Massimiliano</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Biomedicines; Dec2022, Vol. 10 Issue 12, p3034, 11p
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22IMMUNE+response%22">IMMUNE response</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+vaccines%22">COVID-19 vaccines</searchLink><br /><searchLink fieldCode="DE" term="%22MULTIPLE+sclerosis%22">MULTIPLE sclerosis</searchLink><br /><searchLink fieldCode="DE" term="%22INFLAMMATORY+mediators%22">INFLAMMATORY mediators</searchLink><br /><searchLink fieldCode="DE" term="%22PEARSON+correlation+%28Statistics%29%22">PEARSON correlation (Statistics)</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The impact of disease-modifying therapies (DMTs) on the immune response to coronavirus disease-2019 (COVID-19) vaccines in persons with multiple sclerosis (pwMS) needs further elucidation. We investigated BNT162b2 mRNA COVID-19 vaccine effects concerning antibody seroconversion, inflammatory mediators' level and immunophenotype assessment in pwMS treated with cladribine (c-pwMS, n = 29), fingolimod (f-pwMS, n = 15) and ocrelizumab (o-pwMS, n = 54). Anti-spike immunoglobulin (Ig)-G detection was performed by an enzyme immunoassay; molecular mediators (GrB, IFN-γ and TNF-α) were quantified using the ELLA platform, and immunophenotype was assessed by flow cytometry. ANCOVA, Student's t-test and Pearson correlation analyses were applied. Only one o-pwMS showed a mild COVID-19 infection despite most o-pwMS lacking seroconversion and showing lower anti-spike IgG titers than c-pwMS and f-pwMS. No significant difference in cytokine production and lymphocyte count was observed in c-pwMS and f-pwMS. In contrast, in o-pwMS, a significant increase in GrB levels was detected after vaccination. Considering non-seroconverted o-pwMS, a significant increase in GrB serum levels and CD4+ T lymphocyte count was found after vaccination, and a negative correlation was observed between anti-spike IgG production and CD4+ T cells count. Differences in inflammatory mediators' production after BNT162b2 vaccination in o-pwMS, specifically in those lacking anti-spike IgG, suggest a protective cellular immune response. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label:
  Group: Ab
  Data: <i>Copyright of Biomedicines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=160942443
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/biomedicines10123034
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 3034
    Subjects:
      – SubjectFull: IMMUNE response
        Type: general
      – SubjectFull: COVID-19 vaccines
        Type: general
      – SubjectFull: MULTIPLE sclerosis
        Type: general
      – SubjectFull: INFLAMMATORY mediators
        Type: general
      – SubjectFull: PEARSON correlation (Statistics)
        Type: general
    Titles:
      – TitleFull: Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mazziotti, Valentina
      – PersonEntity:
          Name:
            NameFull: Crescenzo, Francesco
      – PersonEntity:
          Name:
            NameFull: Tamanti, Agnese
      – PersonEntity:
          Name:
            NameFull: Dapor, Caterina
      – PersonEntity:
          Name:
            NameFull: Ziccardi, Stefano
      – PersonEntity:
          Name:
            NameFull: Guandalini, Maddalena
      – PersonEntity:
          Name:
            NameFull: Colombi, Annalisa
      – PersonEntity:
          Name:
            NameFull: Camera, Valentina
      – PersonEntity:
          Name:
            NameFull: Peloso, Angela
      – PersonEntity:
          Name:
            NameFull: Pezzini, Francesco
      – PersonEntity:
          Name:
            NameFull: Turano, Ermanna
      – PersonEntity:
          Name:
            NameFull: Marastoni, Damiano
      – PersonEntity:
          Name:
            NameFull: Calabrese, Massimiliano
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 22279059
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Biomedicines
              Type: main
ResultId 1